The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
KIR and disease: a model system or system of models?
Abstract
Summary: The discovery of an unexpected level of diversity among the killer cell immunoglobulin‐like receptors has led to a search for their role in human disease. Due to their polymorphism and also that of their human leukocyte antigen class I ligands, these studies are difficult to perform and complex to interpret. Nevertheless, as the number of data sets increase, consistent trends and themes are beginning to emerge in both viral and inflammatory disorders. In this review, we summarize the findings from a number of disease association studies and discuss these in the context of the activating and inhibitory roles of the members of this gene family.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769
Latest Advances in Understanding Preeclampsia
Redman, C. W., & Sargent, I. L. (2005) · Science · doi:10.1126/science.1111726 · Cited by 2,607
NATURAL KILLER CELLS IN ANTIVIRAL DEFENSE: Function and Regulation by Innate Cytokines
Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P., & Salazar-Mather, T. P. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.189 · Cited by 2,113
Hughes, A. L., & Nei, M. (1988) · Nature · doi:10.1038/335167a0 · Cited by 1,969
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
Groh, V., Wu, J., Yee, C., & Spies, T. (2002) · Nature · doi:10.1038/nature01112 · Cited by 1,592
Licensing of natural killer cells by host major histocompatibility complex class I molecules
Kim, S., Poursine-Laurent, J., Truscott, S. M., Lybarger, L., Song, Y.-J., Yang, L., French, A. R., Sunwoo, J. B., Lemieux, S., Hansen, T. H., et al. (2005) · Nature · doi:10.1038/nature03847 · Cited by 1,340
Severe Herpesvirus Infections in an Adolescent without Natural Killer Cells
Biron, C. A., Byron, K. S., & Sullivan, J. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906293202605 · Cited by 1,269
Direct Recognition of Cytomegalovirus by Activating and Inhibitory NK Cell Receptors
Arase, H., Mocarski, E. S., Campbell, A. E., Hill, A. B., & Lanier, L. L. (2002) · Science · doi:10.1126/science.1070884 · Cited by 1,230
MHC class I molecules and kirs in human history, health and survival
Parham, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1570 · Cited by 1,203
Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS
Martin, M. P., Gao, X., Lee, J.-H., Nelson, G. W., Detels, R., Goedert, J. J., Buchbinder, S., Hoots, K., Vlahov, D., Trowsdale, J., et al. (2002) · Nature Genetics · doi:10.1038/ng934 · Cited by 1,189
Self-citationHLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
Khakoo, S. I., Thio, C. L., Martin, M. P., Brooks, C. R., Gao, X., Astemborski, J., Cheng, J., Goedert, J. J., Vlahov, D., Hilgartner, M., et al. (2004) · Science · doi:10.1126/science.1097670 · Cited by 1,179
Self-citationHiby, S. E., Walker, J. J., O'Shaughnessy, K. M., Redman, C. W. G., Carrington, M., Trowsdale, J., & Moffett, A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20041214 · Cited by 1,121
Self-citationFernandez, N. C., Lozier, A., Flament, C., Ricciardi-Castagnoli, P., Bellet, D., Suter, M., Perricaudet, M., Tursz, T., Maraskovsky, E., & Zitvogel, L. (1999) · Nature Medicine · doi:10.1038/7403 · Cited by 1,060
Human Diversity in Killer Cell Inhibitory Receptor Genes
Uhrberg, M., Valiante, N. M., Shum, B. P., Shilling, H. G., Lienert-Weidenbach, K., Corliss, B., Tyan, D., Lanier, L. L., & Parham, P. (1997) · Immunity · doi:10.1016/s1074-7613(00)80394-5 · Cited by 1,059
Reciprocal Activating Interaction between Natural Killer Cells and Dendritic Cells
Gerosa, F., Baldani-Guerra, B., Nisii, C., Marchesini, V., Carra, G., & Trinchieri, G. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20010938 · Cited by 1,028
Ferlazzo, G., Tsang, M. L., Moretta, L., Melioli, G., Steinman, R. M., & Münz, C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011149 · Cited by 994
KIR: Diverse, Rapidly Evolving Receptors of Innate and Adaptive Immunity
Vilches, C., & Parham, P. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.092501.134942 · Cited by 986
Human Decidual Natural Killer Cells Are a Unique NK Cell Subset with Immunomodulatory Potential
Koopman, L. A., Kopcow, H. D., Rybalov, B., Boyson, J. E., Orange, J. S., Schatz, F., Masch, R., Lockwood, C. J., Schachter, A. D., Park, P. J., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030305 · Cited by 909
Imprint of human cytomegalovirus infection on the NK cell receptor repertoire
Gumá, M., Angulo, A., Vilches, C., Gómez-Lozano, N., Malats, N., & López-Botet, M. (2004) · Blood · doi:10.1182/blood-2004-05-2058 · Cited by 865
Cohen, G. B., Gandhi, R. T., Davis, D. M., Mandelboim, O., Chen, B. K., Strominger, J. L., & Baltimore, D. (1999) · Immunity · doi:10.1016/s1074-7613(00)80065-5 · Cited by 861
Implications for immunosurveillance of altered HLA class I phenotypes in human tumours
Garrido, F., Ruiz-Cabello, F., Cabrera, T., Pérez-Villar, J. J., López-Botet, M., Duggan-Keen, M., & Stern, P. L. (1997) · Immunology Today · doi:10.1016/s0167-5699(96)10075-x · Cited by 770
Recognition of a virus-encoded ligand by a natural killer cell activation receptor
Smith, H. R. C., Heusel, J. W., Mehta, I. K., Kim, S., Dorner, B. G., Naidenko, O. V., Iizuka, K., Furukawa, H., Beckman, D. L., Pingel, J. T., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092258599 · Cited by 767
Ikeda, H., Lethé, B., Lehmann, F., Van Baren, N., Baurain, J.-F., De Smet, C., Chambost, H., Vitale, M., Moretta, A., Boon, T., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80426-4 · Cited by 762
New aspects of natural-killer-cell surveillance and therapy of cancer
Smyth, M. J., Hayakawa, Y., Takeda, K., & Yagita, H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc928 · Cited by 752
Alter, H. J., & Seeff, L. B. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9505 · Cited by 736
Rajagopalan, S., & Long, E. O. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.7.1093 · Cited by 726
The Influence of HLA Genotype on AIDS
Carrington, M., & O'Brien, S. J. (2003) · Annual Review of Medicine · doi:10.1146/annurev.med.54.101601.152346 · Cited by 722
Self-citationContact-dependent Stimulation and Inhibition of Dendritic Cells by Natural Killer Cells
Piccioli, D., Sbrana, S., Melandri, E., & Valiante, N. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20010934 · Cited by 701
Clonal diseases of large granular lymphocytes [see comments]
Loughran, T. J. (1993) · Blood · doi:10.1182/blood.v82.1.1.bloodjournal8211 · Cited by 697
Takahata, N., & Nei, M. (1990) · Genetics · doi:10.1093/genetics/124.4.967 · Cited by 676
Tomasec, P., Braud, V. M., Rickards, C., Powell, M. B., McSharry, B. P., Gadola, S., Cerundolo, V., Borysiewicz, L. K., McMichael, A. J., & Wilkinson, G. W. G. (2000) · Science · doi:10.1126/science.287.5455.1031 · Cited by 661
Ferlazzo, G., Pack, M., Thomas, D., Paludan, C., Schmid, D., Strowig, T., Bougras, G., Muller, W. A., Moretta, L., & Münz, C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407522101 · Cited by 583
Mavilio, D., Lombardo, G., Benjamin, J., Kim, D., Follman, D., Marcenaro, E., O'Shea, M. A., Kinter, A., Kovacs, C., Moretta, A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409872102 · Cited by 544
Yawata, M., Yawata, N., Draghi, M., Little, A.-M., Partheniou, F., & Parham, P. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051884 · Cited by 520
Gumperz, J. E., Litwin, V, Phillips, J. H., Lanier, L. L., & Parham, P. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.1133 · Cited by 509
Human placental HLA-G expression is restricted to differentiated cytotrophoblasts.
McMaster, M. T., Librach, C. L., Zhou, Y., Lim, K. H., Janatpour, M. J., DeMars, R., Kovats, S., Damsky, C., & Fisher, S. J. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.8.3771 · Cited by 472
Colonna, M., Borsellino, G., Falco, M., Ferrara, G. B., & Strominger, J. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.12000 · Cited by 460
HPV‐mediated cervical carcinogenesis: concepts and clinical implications
Snijders, P. J., Steenbergen, R. D., Heideman, D. A., & Meijer, C. J. (2006) · The Journal of Pathology · doi:10.1002/path.1866 · Cited by 455
Hsu, K. C., Chida, S., Geraghty, D. E., & Dupont, B. (2002) · Immunological Reviews · doi:10.1034/j.1600-065x.2002.19004.x · Cited by 443
Winter, C. C., Gumperz, J. E., Parham, P., Long, E. O., & Wagtmann, N. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.571 · Cited by 422
Interplay of natural killer cells and their receptors with the adaptive immune response
Raulet, D. H. (2004) · Nature Immunology · doi:10.1038/ni1114 · Cited by 413
Recognition of peptide–MHC class I complexes by activating killer immunoglobulin-like receptors
Stewart, C. A., Laugier-Anfossi, F., Vély, F., Saulquin, X., Riedmuller, J., Tisserant, A., Gauthier, L., Romagné, F., Ferracci, G., Arosa, F. A., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503594102 · Cited by 406
Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand
Boyington, J. C., Motyka, S. A., Schuck, P., Brooks, A. G., & Sun, P. D. (2000) · Nature · doi:10.1038/35014520 · Cited by 404
Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus
Arnon, T. I., Achdout, H., Levi, O., Markel, G., Saleh, N., Katz, G., Gazit, R., Gonen-Gross, T., Hanna, J., Nahari, E., et al. (2005) · Nature Immunology · doi:10.1038/ni1190 · Cited by 397
Mavilio, D., Benjamin, J., Daucher, M., Lombardo, G., Kottilil, S., Planta, M. A., Marcenaro, E., Bottino, C., Moretta, L., Moretta, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336091100 · Cited by 387
Hsu, K. C., Liu, X.-R., Selvakumar, A., Mickelson, E., O’Reilly, R. J., & Dupont, B. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.5118 · Cited by 381
Salazar-Mather, T. P., Orange, J. S., & Biron, C. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.1.1 · Cited by 375
Alter, G., Teigen, N. C., Davis, B. T., Addo, M. M., Suscovich, T. J., Waring, M. T., Streeck, H., Johnston, M. N., Staller, K. D., Zaman, M. T., et al. (2005) · Blood · doi:10.1182/blood-2005-03-1100 · Cited by 373
Pende, D., Biassoni, R., Cantoni, C., Verdiani, S., Falco, M., di Donato, C., Accame, L., Bottino, C., Moretta, A., & Moretta, L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.505 · Cited by 365
Ponte, M., Cantoni, C., Biassoni, R., Tradori-Cappai, A., Bentivoglio, G., Vitale, C., Bertone, S., Moretta, A., Moretta, L., & Mingari, M. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5674 · Cited by 364
Activation of NK Cells by an Endocytosed Receptor for Soluble HLA-G
Rajagopalan, S., Bryceson, Y. T., Kuppusamy, S. P., Geraghty, D. E., Meer, A. V. D., Joosten, I., & Long, E. O. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0040009 · Cited by 353
A human killer inhibitory receptor specific for HLA-A1,2
Döhring, C., Scheidegger, D., Samaridis, J., Cella, M., & Colonna, M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.9.3098 · Cited by 349
Cella, M., Longo, A., Ferrara, G. B., Strominger, J. L., & Colonna, M. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1235 · Cited by 340
Human decidual NK cells form immature activating synapses and are not cytotoxic
Kopcow, H. D., Allan, D. S. J., Chen, X., Rybalov, B., Andzelm, M. M., Ge, B., & Strominger, J. L. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507835102 · Cited by 339
Human natural killer cell deficiencies and susceptibility to infection
Orange, J. S. (2002) · Microbes and Infection · doi:10.1016/s1286-4579(02)00038-2 · Cited by 338
Wagtmann, N., Rajagopalan, S., Winter, C. C., Peruui, M., & Long, E. O. (1995) · Immunity · doi:10.1016/1074-7613(95)90069-1 · Cited by 335
Yen, J.-H., Moore, B. E., Nakajima, T., Scholl, D., Schaid, D. J., Weyand, C. M., & Goronzy, J. J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.10.1159 · Cited by 335
Wu, J. D., Higgins, L. M., Steinle, A., Cosman, D., Haugk, K., & Plymate, S. R. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422206 · Cited by 330
Martin, M. P., Nelson, G., Lee, J.-H., Pellett, F., Gao, X., Wade, J., Wilson, M. J., Trowsdale, J., Gladman, D., & Carrington, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.2818 · Cited by 328
Self-citationEVIDENCE FOR BALANCING SELECTION AT HLA
Hedrick, P. W., & Thomson, G. (1983) · Genetics · doi:10.1093/genetics/104.3.449 · Cited by 318
Natural killer cells in human health and disease
Orange, J. S., & Ballas, Z. K. (2006) · Clinical Immunology · doi:10.1016/j.clim.2005.10.011 · Cited by 318
Recognition of HLA‐A3 and HLA‐A11 by KIR3DL2 is peptide‐specific
Hansasuta, P., Dong, T., Thananchai, H., Weekes, M., Willberg, C., Aldemir, H., Rowland‐Jones, S., & Braud, V. M. (2004) · European Journal of Immunology · doi:10.1002/eji.200425089 · Cited by 318
Ulbrecht, M., Martinozzi, S., Grzeschik, M., Hengel, H., Ellwart, J. W., Pla, M., & Weiss, E. H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.5019 · Cited by 310
NK cells in HIV infection: Paradigm for protection or targets for ambush
Fauci, A. S., Mavilio, D., & Kottilil, S. (2005) · Nature Reviews Immunology · doi:10.1038/nri1711 · Cited by 306
Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen.
Scalzo, A. A., Fitzgerald, N. A., Simmons, A., La Vista, A. B., & Shellam, G. R. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.5.1469 · Cited by 304
Comparative Genomics of Natural Killer Cell Receptor Gene Clusters
Kelley, J., Walter, L., & Trowsdale, J. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010027 · Cited by 290 · cited 1×
“KIR2DL4 is present on virtually all KIR haplotypes, is ubiquitously expressed by all NK cells, and is the only clear KIR gene orthologue across apes and Old-World monkeys (135), suggesting a distinctly important function of the KIR2DL4 molecule.”
BackgroundCross-Talk between Activated Human NK Cells and CD4+ T Cells via OX40-OX40 Ligand Interactions
Zingoni, A., Sornasse, T., Cocks, B. G., Tanaka, Y., Santoni, A., & Lanier, L. L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3716 · Cited by 283
Unusual HLA-B alleles in two tribes of Brazilian Indians
Belich, M. P., Madrigal, J. A., Hildebrand, W. H., Zemmour, J., Williams, R. C., Luz, R., Petzl-Erler, M. L., & Parham, P. (1992) · Nature · doi:10.1038/357326a0 · Cited by 282
Surface Expression of HLA-C Antigen by Human Extravillous Trophoblast
King, A., Burrows, T. D., Hiby, S. E., Bowen, J. M., Joseph, S., Verma, S., Lim, P. B., Gardner, L., Le Bouteiller, P., Ziegler, A., et al. (2000) · Placenta · doi:10.1053/plac.1999.0496 · Cited by 279
Rapid Evolution of NK Cell Receptor Systems Demonstrated by Comparison of Chimpanzees and Humans
Khakoo, S. I., Rajalingam, R., Shum, B. P., Weidenbach, K., Flodin, L., Muir, D. G., Canavez, F., Cooper, S. L., Valiante, N. M., Lanier, L. L., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)80219-8 · Cited by 277
Self-citationNelson, G. W., Martin, M. P., Gladman, D., Wade, J., Trowsdale, J., & Carrington, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.7.4273 · Cited by 276
Self-citationAllelic Polymorphism Synergizes with Variable Gene Content to Individualize Human KIR Genotype
Shilling, H. G., Guethlein, L. A., Cheng, N. W., Gardiner, C. M., Rodriguez, R., Tyan, D., & Parham, P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2307 · Cited by 275
Downregulation of natural killer cell–activating ligand CD155 by human cytomegalovirus UL141
Tomasec, P., Wang, E. C. Y., Davison, A. J., Vojtesek, B., Armstrong, M., Griffin, C., McSharry, B. P., Morris, R. J., Llewellyn-Lacey, S., Rickards, C., et al. (2005) · Nature Immunology · doi:10.1038/ni1156 · Cited by 271
Natural killer cells and viral infections
French, A. R., & Yokoyama, W. M. (2003) · Current Opinion in Immunology · doi:10.1016/s095279150200002x · Cited by 269
Gardiner, C. M., Guethlein, L. A., Shilling, H. G., Pando, M., Carr, W. H., Rajalingam, R., Vilches, C., & Parham, P. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.5.2992 · Cited by 264
Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity
Flores-Villanueva, P. O., Yunis, E. J., Delgado, J. C., Vittinghoff, E., Buchbinder, S., Leung, J. Y., Uglialoro, A. M., Clavijo, O. P., Rosenberg, E. S., Kalams, S. A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071548198 · Cited by 263
Uhrberg, M., Parham, P., & Wernet, P. (2002) · Immunogenetics · doi:10.1007/s00251-002-0463-7 · Cited by 260
Chiesa, M. D., Vitale, M., Carlomagno, S., Ferlazzo, G., Moretta, L., & Moretta, A. (2003) · European Journal of Immunology · doi:10.1002/eji.200323986 · Cited by 258
Watkins, D. I., McAdam, S. N., Liu, X., Strang, C. R., Milford, E. L., Levine, C. G., Garber, T. L., Dogon, A. L., Lord, C. I., Ghim, S. H., et al. (1992) · Nature · doi:10.1038/357329a0 · Cited by 248
Genetic Control of Human NK Cell Repertoire
Shilling, H. G., Young, N., Guethlein, L. A., Cheng, N. W., Gardiner, C. M., Tyan, D., & Parham, P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.239 · Cited by 245
(1989) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a040573 · Cited by 235
Carrington, M., Wang, S., Martin, M. P., Gao, X., Schiffman, M., Cheng, J., Herrero, R., Rodriguez, A. C., Kurman, R., Mortel, R., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042158 · Cited by 231
Self-citationKIR3DL1 Polymorphisms That Affect NK Cell Inhibition by HLA-Bw4 Ligand
Carr, W. H., Pando, M. J., & Parham, P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.8.5222 · Cited by 224
van der Slik, A. R., Koeleman, B. P. C., Verduijn, W., Bruining, G. J., Roep, B. O., & Giphart, M. J. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2639 · Cited by 224
Understanding how combinations of HLA and KIR genes influence disease
Rajagopalan, S., & Long, E. O. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050499 · Cited by 220
Biassoni, R., Pessino, A., Malaspina, A., Cantoni, C., Bottino, C., Sivori, S., Moretta, L., & Moretta, A. (1997) · European Journal of Immunology · doi:10.1002/eji.1830271203 · Cited by 213
Pando, M. J., Gardiner, C. M., Gleimer, M., McQueen, K. L., & Parham, P. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6640 · Cited by 212
Namekawa, T., Snyder, M. R., Yen, J.-H., Goehring, B. E., Leibson, P. J., Weyand, C. M., & Goronzy, J. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.1138 · Cited by 210
Natural killer cell activation in mice and men: different triggers for similar weapons?
Colucci, F., Di Santo, J. P., & Leibson, P. J. (2002) · Nature Immunology · doi:10.1038/ni0902-807 · Cited by 207
Rajagopalan, S., & Long, E. O. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.8.1523 · Cited by 206
Distribution of natural killer cell immunoglobulin-like receptor sequences in three ethnic groups
Chandanayingyong, D., Vaughan, R. W., Verity, D. H., Norman, P. J., & Stephens, H. A. F. (2001) · Immunogenetics · doi:10.1007/s002510000281 · Cited by 200
Artavanis-Tsakonas, K., Eleme, K., McQueen, K. L., Cheng, N. W., Parham, P., Davis, D. M., & Riley, E. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5396 · Cited by 199
Yawata, M., Yawata, N., McQueen, K., Cheng, N., Guethlein, L., Rajalingam, R., Shilling, H., & Parham, P. (2002) · Immunogenetics · doi:10.1007/s00251-002-0497-x · Cited by 196
Expression of killer cell inhibitory receptors on human uterine natural killer cells
Verma, S., King, A., & Loke, Y. W. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270426 · Cited by 185
Kikuchi-Maki, A., Yusa, S.-I., Catina, T. L., & Campbell, K. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3415 · Cited by 182
Genomic diversity of natural killer cell receptor genes in three populations
Toneva, M., Lepage, V., Lafay, G., Dulphy, N., Busson, M., Lester, S., Vu‐Trien, A., Michaylova, A., Naumova, E., McCluskey, J., et al. (2001) · Tissue Antigens · doi:10.1034/j.1399-0039.2001.057004358.x · Cited by 178
Young, N. T., Uhrberg, M., Phillips, J. H., Lanier, L. L., & Parham, P. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.3933 · Cited by 177
Meier, U.-C., Owen, R. E., Taylor, E., Worth, A., Naoumov, N., Willberg, C., Tang, K., Newton, P., Pellegrino, P., Williams, I., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.19.12365-12374.2005 · Cited by 174
Morice, W. G., Kurtin, P. J., Leibson, P. J., Tefferi, A., & Hanson, C. A. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04201.x · Cited by 169
Uhrberg, M., Valiante, N., Young, N., Lanier, L., Phillips, J., & Parham, P. (2001) · Journal of Immunology · doi:10.4049/jimmunol.166.6.3923 · Cited by 168
Baratin, M., Roetynck, S., Lépolard, C., Falk, C., Sawadogo, S., Uematsu, S., Akira, S., Ryffel, B., Tiraby, J.-G., Alexopoulou, L., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507355102 · Cited by 167
Bonaparte, M. I., & Barker, E. (2004) · Blood · doi:10.1182/blood-2004-02-0696 · Cited by 158
Kikuchi-Maki, A., Catina, T. L., & Campbell, K. S. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.7.3859 · Cited by 157
Łuszczek, W., Mańczak, M., Cisło, M., Nockowski, P., Wiśniewski, A., Jasek, M., & Kuśnierczyk, P. (2004) · Human Immunology · doi:10.1016/j.humimm.2004.05.008 · Cited by 155
Maxwell, L. D., Wallace, A., Middleton, D., & Curran, M. D. (2002) · Tissue Antigens · doi:10.1034/j.1399-0039.2002.600307.x · Cited by 149
Natural killer cells and innate immunity to protozoan pathogens
Korbel, D. S., Finney, O. C., & Riley, E. M. (2004) · International Journal for Parasitology · doi:10.1016/j.ijpara.2004.10.006 · Cited by 147
Association of killer cell immunoglobulin‐like receptors with scleroderma
Momot, T., Koch, S., Hunzelmann, N., Krieg, T. M., Ulbricht, K. U., Schmidt, R. E., & Witte, T. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20216 · Cited by 141
Phenotypic and Functional Characterization of CD4 T Cells Expressing Killer Ig-Like Receptors
van Bergen, J., Thompson, A., van der Slik, A. R., Ottenhoff, T. H. M., Gussekloo, J., & Koning, F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6719 · Cited by 139
Peptide sequence requirements for the recognition of HLA-B*2705 by specific natural killer cells
Peruzzi, M., Parker, K. C., Long, E. O., & Malnati, M. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.8.3350 · Cited by 137
Suzuki, Y., Hamamoto, Y., Ogasawara, Y., Ishikawa, K., Yoshikawa, Y., Sasazuki, T., & Muto, M. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22517.x · Cited by 135
Cutting Edge: Expansion of the KIR Locus by Unequal Crossing Over
Martin, M. P., Bashirova, A. A., Traherne, J. A., Trowsdale, J., & Carrington, M. N. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.5.2192 · Cited by 134
Self-citationMaenaka, K., Juji, T., Nakayama, T., Wyer, J. R., Gao, G., Maenaka, T., Zaccai, N., Kikuchi, A., Yabe, T., Tokunaga, K., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.40.28329 · Cited by 134
Sambrook, J., Bashirova, A. A., Palmer, S., Sims, S. K., Trowsdale, J., Abi‐Rached, L., Parham, P., Carrington, M. N., & Beck, S. (2005) · Genome Research · doi:10.1101/gr.2381205 · Cited by 131
Self-citationGaudieri, S., DeSantis, D., McKinnon, E., Moore, C., Nolan, D. A., Witt, C. S., Mallal, S. A., & Christiansen, F. (2005) · Genes and Immunity · doi:10.1038/sj.gene.6364256 · Cited by 128
Nakajima, T., Goek, O., Zhang, X., Kopecky, S. L., Frye, R. L., Goronzy, J. J., & Weyand, C. M. (2003) · Circulation Research · doi:10.1161/01.res.0000082333.58263.58 · Cited by 127 · cited 1×
“Consistentwith a role forKIR-positive T cells in vascular inflammation, CD4þCD28 KIR2DS2þ T cells are foundmore frequently in the peripheral blood of individuals with acute coronary artery syndromes than in control individuals (153).”
BackgroundThe Impact of Variation at the KIR Gene Cluster on Human Disease
Carrington, M. N., & Martin, M. P. (2005) · Current topics in microbiology and immunology · doi:10.1007/3-540-27743-9_12 · Cited by 127
Self-citationKatz, G., Markel, G., Mizrahi, S., Arnon, T. I., & Mandelboim, O. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7260 · Cited by 126
Domain Shuffling Has Been the Main Mechanism Forming New Hominoid Killer Cell Ig-Like Receptors
Rajalingam, R., Parham, P., & Abi‐Rached, L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.356 · Cited by 125
The Role of NK Cells in Autoimmune Disease
Baxter, A. G., & Smyth, M. J. (2002) · Autoimmunity · doi:10.1080/08916930290005864 · Cited by 125
Diversity of the Killer Cell Ig-Like Receptors of Rhesus Monkeys
Hershberger, K. L., Shyam, R., Miura, A., & Letvin, N. L. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.7.4380 · Cited by 124
Denis, L., Sivula, J., Gourraud, P., Kerdudou, N., Chout, R., Ricard, C., Moisan, J., Gagne, K., Partanen, J., & Bignon, J. (2005) · Tissue Antigens · doi:10.1111/j.1399-0039.2005.00473.x · Cited by 120
Zambello, R., Falco, M., Chiesa, M. D., Trentin, L., Carollo, D., Castriconi, R., Cannas, G., Carlomagno, S., Cabrelle, A., Lamy, T., et al. (2003) · Blood · doi:10.1182/blood-2002-12-3898 · Cited by 117
Zappacosta, F., Borrego, F., Brööks, A. G., Parker, K. C., & Coligan, J. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6313 · Cited by 115
MHC Class I-Independent Recognition of NK-Activating Receptor KIR2DS4
Katz, G., Gazit, R., Arnon, T. I., Gonen‐Gross, T., Tarcic, G., Markel, G., Gruda, R., Achdout, H., Drize, O., Merims, S., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.1819 · Cited by 115
Stern‐Ginossar, N., Markel, G., Arnon, T. I., Gruda, R., Wong, H., Gray‐Owen, S. D., & Mandelboim, O. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.11.6692 · Cited by 113
Natural killer cells infiltrating colorectal cancer and MHC class I expression
Sandel, M. H., Speetjens, F. M., Menon, A. G., Albertsson, P., Basse, P. H., Hokland, M., Nagelkerke, J. F., Tollenaar, R. A. E. M., van de Velde, C. J. �., & Kuppen, P. J. K. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.07.039 · Cited by 112
Williams, F., Meenagh, A., Sleator, C., Cook, D., Fernández-Viña, M., Bowcock, A. M., & Middleton, D. (2005) · Human Immunology · doi:10.1016/j.humimm.2005.04.005 · Cited by 110
Henseler, T. (1997) · PubMed · Cited by 109
Guethlein, L. A., Flodin, L. R., Adams, E. J., & Parham, P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.220 · Cited by 106
Heterozygosity at individual amino acid sites: extremely high levels for HLA-A and -B genes.
Hedrick, P. W., Whittam, T. S., & Parham, P. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.13.5897 · Cited by 101
Rajalingam, R., Hong, M., Adams, E. J., Shum, B. P., Guethlein, L. A., & Parham, P. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.1.135 · Cited by 98
Development and tolerance of natural killer cells
Raulet, D. H. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80023-5 · Cited by 96
A long‐term study of patients with chronic natural killer cell lymphocytosis
Rabbani, G. R., Phyliky, R. L., & Tefferi, A. (1999) · British Journal of Haematology · doi:10.1046/j.1365-2141.1999.01624.x · Cited by 96
Barber, L. D., Percival, L., Valiante, N. M., Chen, L., Lee, C., Gumperz, J. E., Phillips, J. H., Lanier, L. L., Bigge, J. C., Parekh, R. B., et al. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.2.735 · Cited by 96
Natural Killer (NK) Cell Receptors' Repertoire in Couples with Recurrent Spontaneous Abortions
Varla-Leftherioti, M., Spyropoulou‐Vlachou, M., Niokou, D., Keramitsoglou, T., Darlamitsou, A., Tsekoura, C., Papadimitropoulos, M., Lepage, V., Balafoutas, C., & Stavropoulos‐Giokas, C. (2003) · American Journal of Reproductive Immunology · doi:10.1034/j.1600-0897.2003.00018.x · Cited by 93
Henseler, T. (1997) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(97)80394-5 · Cited by 91
Epling-Burnette, P., Painter, J., Chaurasia, P., Bai, F.-Q., Wei, S., Djeu, J., & Loughran, T. (2004) · Blood · doi:10.1182/blood-2003-02-0400 · Cited by 90
López‐Vázquez, A., Miña‐Blanco, A., Martı́nez-Borra, J., Njobvu, P., Suárez-Álvarez, B., Blanco-Gelaz, M. Á., Gonzalez, S. R., Rodrigo, L., & López‐Larrea, C. (2005) · Human Immunology · doi:10.1016/j.humimm.2005.01.001 · Cited by 87
The miscarriage-associated HLA-G –725G allele influences transcription rates in JEG-3 cells
Ober, C., Billstrand, C., Kuldanek, S. A., & Tan, Z. (2006) · Human Reproduction · doi:10.1093/humrep/del036 · Cited by 85
Vely, F., Peyrat, M., Couedel, C., Morcet, J., Halary, F. A., Davodeau, F., Romagné, F., Scotet, E., Saulquin, X., Houssaint, E., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2487 · Cited by 84
Snyder, M. R., Nakajima, T. E., Leibson, P. J., Weyand, C. M., & Goronzy, J. J. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3725 · Cited by 83
Distinct HLA-C/KIR Genotype Profile Associates with Guttate Psoriasis
Holm, S. J., Sakuraba, K., Mallbris, L., Wolk, K., Ståhle, M., & Sánchez, F. O. N. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23879.x · Cited by 76
Naumova, E. J., Mihaylova, A., Stoitchkov, K., Ivanova, M., Quin, L., & Toneva, M. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0575-z · Cited by 76
Pascal, V., SCHLEINITZ, N., Brunet, C., Ravet, S., Bonnet, E., Lafarge, X., Touinssi, M., Reviron, D., Viallard, J., Viallard, J., et al. (2004) · European Journal of Immunology · doi:10.1002/eji.200425146 · Cited by 73
HLA-C and Killer Cell Immunoglobulin-like Receptor Genes in Idiopathic Bronchiectasis
Boyton, R. J., Smith, J. D., Ward, R. D., Jones, M. C., Ozerovitch, L., Wilson, R., Rose, M. L., Trowsdale, J., & Altmann, D. M. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200501-124oc · Cited by 72
Expression of KIR2DL1 on the entire NK cell population: a possible novel immunodeficiency syndrome
Gazit, R., Garty, B., Monselise, Y., Hoffer, V., Finkelstein, Y., Markel, G., Katz, G., Hanna, J. H., Achdout, H., Gruda, R., et al. (2004) · Blood · doi:10.1182/blood-2003-11-3796 · Cited by 72
Molecular characterization of KIR3DL3
Trundley, A., Hiby, S. E., Chang, C., Sharkey, A., Santourlidis, S., Uhrberg, M., Trowsdale, J., & Moffett, A. (2006) · Immunogenetics · doi:10.1007/s00251-005-0060-7 · Cited by 69
Recognition of HLA‐G by the NK cell receptor KIR2DL4 is not essential for human reproduction
Gómez‐Lozano, N., de Pablo, R., Puente, S., & Vilches, C. (2003) · European Journal of Immunology · doi:10.1002/eji.200323741 · Cited by 67
Evolution of natural killer cell receptors
Mager, D. L., McQueen, K. L., Wee, V., & Freeman, J. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00148-8 · Cited by 56
Natural killer cells and reproduction
Moffett-King, A., Entrican, G., Ellis, S. A., Hutchinson, J. A., & Bainbridge, D. R. J. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02261-5 · Cited by 53
Ņikitina-Zaķe, L., RAJALINGHAM, R., Rumba, I., & Sanjeevi, C. B. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1337.027 · Cited by 53
HLA‐G polymorphism in a Chinese Han population with recurrent spontaneous abortion
Yan, W., Li, F., Yang, J., et al. (2006) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2006.00567.x · Cited by 46
Justified chauvinism: advances in defining meiotic recombination through sperm typing
Carrington, M. N., & Cullen, M. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.02.006 · Cited by 44
Self-citationHershberger, K. L., Kurian, J., Korber, B., & Letvin, N. L. (2005) · European Journal of Immunology · doi:10.1002/eji.200425408 · Cited by 37
Norris, S., Doherty, D. G., Curry, M., McEntee, G., Traynor, O., Hegarty, J. E., & O’Farrelly, C. (2003) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-002-0331-1 · Cited by 34
Carr, W. (2002) · Clinical Immunology · doi:10.1006/clim.2002.5273 · Cited by 30
Effects of Cytokines on VEGF Expression and Secretion by Human First Trimester Trophoblast Cell Line
Choi, S. J., PARK, J. Y., Lee, Y. K., Choi, H. I., LEE, Y. S., Koh, C.-M., & Chung, I.-B. (2002) · American Journal of Reproductive Immunology · doi:10.1034/j.1600-0897.2002.01071.x · Cited by 29
Mitsui, T., Maekawa, I., Yamane, A., Ishikawa, T., Koiso, H., Yokohama, A., Handa, H., Matsushima, T., Tsukamoto, N., Murakami, H., et al. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05005.x · Cited by 16
Tsuchihashi (2000) · doi:10.1002/1521-4141(200006)30:6
Cited by
Innate or adaptive immunity? The example of natural killer cells
Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., Yokoyama, W. M., & Ugolini, S. (2011) · Science · doi:10.1126/science.1198687 · Cited by 2,824
The HLA genomic loci map: expression, interaction, diversity and disease
Shiina, T., Hosomichi, K., Inoko, H., & Kulski, J. K. (2009) · Journal of Human Genetics · doi:10.1038/jhg.2008.5 · Cited by 782
Béziat, V., Liu, L. L., Malmberg, J.-A., Ivarsson, M. A., Sohlberg, E., Björklund, A. T., Retière, C., Sverremark-Ekström, E., Traherne, J., Ljungman, P., et al. (2013) · Blood · doi:10.1182/blood-2012-10-459545 · Cited by 512
Moesta, A. K., Norman, P. J., Yawata, M., Yawata, N., Gleimer, M., & Parham, P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.3969 · Cited by 379
Negative signaling by inhibitory receptors: the NK cell paradigm
Long, E. O. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00660.x · Cited by 370
Metadata
- Authors
- Khakoo, S. I., & Carrington, M.
- Venue
- Immunological Reviews
- Publisher
- Wiley
- Published
- 2006-11-07
- Volume
- 214
- Issue
- 1
- Pages
- 186-201
- ISSN
- 0105-2896 (ISSN-L)
- 1600-065X
- OpenAlex
- W2132756351
- Cited by
- 280
- References
- 160
- FWCI
- 1.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.